|
|
Volumn 30, Issue 5, 1998, Pages 2189-2191
|
|
Role of therapeutic drug monitoring of rapamycin
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
INTERLEUKIN 2 ANTIBODY;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
STEROID;
UNCLASSIFIED DRUG;
AREA UNDER THE CURVE;
BONE MARROW SUPPRESSION;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG MONITORING;
DRUG SAFETY;
HUMAN;
HYPERLIPIDEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
NEPHROTOXICITY;
ORGAN TRANSPLANTATION;
PRIORITY JOURNAL;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
POLYENES;
SIROLIMUS;
|
|
EID: 0031661732
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00586-7 Document Type: Conference Paper |
|
Times cited : (28)
|
|
References (21)
|
